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Abstract:
Background: Equine obstructive pulmonary disease, also known as heaves or recurrent airway obstruction (RAO) is a common equine pulmonary disease with some similarities to human asthma and COPD, which represents a major cause of morbidity and loss of lung performance. Salbutamol has been widely used for the treatment of human airway diseases and has usually been prepared as the racemic form of the drug. However, recently the R-enantiomer of salbutamol has been introduced into clinical practice in the treatment of asthma in humans and this has been suggested to be an improvement on the racemic form of the drug; therefore thus the S-enantiomer has been demonstrated to have adverse effects in the lung and thus using the R-enantiomer may improve the therapeutic ratio. However, little is known about the properties of the R-and S-enantiomers of salbutamol in equine airways and the present study has evaluated the relaxant effects of racemic β 2 agonists in comparison with the R-and S-enantiomers in isolated equine isolated bronchi, as well as the bronchoprotective effects of these drugs on cholinergic and histaminergic pathway.
Methods:
We have studied the effects of the R-and S-enantiomers of salbutamol on bronchi isolated from RAO-affected or unaffected horses. The first study assayed the relaxant effects of R-and S-salbutamol on isolated bronchial rings contracted with carbachol or histamine at a submaximal concentration (EC70). A second study evaluated the effects of R-and S-salbutamol on semi-logarithmic cumulative concentration response curves induced by carbachol or histamine. Specific software was used to calculate statistical significance and the appropriate sigmoidal curve-fitting model. 
Results

Introduction
There is an increasing amount of evidence demonstrating an association of inhaled β 2 agonists with a rise in asthma-related deaths and life-threatening experiences, as well as an ability of β 2 -agonists to induce bronchial hyperresponsiveness when used clinically, particularly when administered as monotherapy [1] . The mechanisms contributing to the adverse effects in the airways are not known, but it has been suggested that some of these undesirable effects maybe due to the S-enantiomer as most commonly available β 2 agonists are produced as racemic mixtures of R-and S-enantiomers in equal ratios [2] .
The S-enantiomer of salbutamol has been considered to be largely inert or at best to have weak β 2 -agonist activities. However, recent studies have documented that S-salbutamol can potentiate the effects of spasmogens in airway smooth muscle from both guinea-pigs and humans , with a number of clinical studies also reporting worsening of airways hyperresponsiveness in animals [3] and in subjects with asthma [4] . It has also been documented that the metabolic clearance of S-salbutamol occurs much less rapidly than Rsalbutamol [5] , and thus the paradoxical responses may persist after the beneficial effects of (R)-salbutamol have waned [2] , particularly after chronic use of the drug. S-salbutamol has also been reported to have proinflammatory effects that could negatively affect the airways [6] .
Chemically, all β-agonists are racemates, or drugs composed of two non-superimposable mirror image molecules in a 50/50 ratio [7] . These molecules are classified as R-or Saccording to their molecular configuration, and as 'lev' or 'dex' based on the rotation of polarised light as it passes through the molecule.
Equine obstructive pulmonary disease, also known as heaves or recurrent airway obstruction (RAO) is a common equine pulmonary disease with certain similarities to human asthma and COPD and represents a major cause of morbidity and loss of lung performance in this species [8, 9] . 
Materials and Methods
Equine lungs, derived from healthy horses following humane killing in an abattoir, were The tissue responsiveness was assessed using acetylcholine (ACh) 100 µM; when the response reached a plateau, rings were washed three times and allowed to equilibrate for a further 60 min.
Study design
Protocol 1: Relaxant effect of salbutamol enantiomers on submaximal contractions induced by carbachol or histamine.
Following equilibration of the tissues, semi-logarithmic concentration-response curves induced by carbachol (dose from 10 nM to 100 µM) or histamine (10 nM to 100 µM) were constructed in order to establish the baseline contractility of tissues and the concentration inducing a sub-maximal contraction (70%). The bronchial rings were washed a further three times and allowed to stabilize for about 30 min following the last washing.
In order to evaluate the relaxant effects of salbutamol enantiomers, in all rings contracted with carbachol and histamine at the sub maximal concentration (EC70), a concentration semi-logarithmic curve to salbutamol enantiomers or the racemic mixture was constructed at concentrations ranging from 0.1nM to 100µM for each compound. Each concentrationresponse curve was obtained by the cumulative addition of R-, S-or racemic salbutamol at intervals of 5-15 min to reach a stable level of relaxation before the next addition was made. In the control groups a cumulative concentration of vehicle was added in the organ- In order to evaluate the effects of salbutamol enantiomers on carbachol and histamineinduced contraction , concentration-contraction semi-logarithmic curves to carbachol or histamine (10 nM to 100 µM) were constructed from bronchi pre-incubated with R-, S-or racemic salbutamol (100 µM) for 90 min. The control bronchi were pre-incubated with vehicle which also served as a time control.
Analysis
All experiments were carried out on bronchi isolated from the lungs of six different horses 
Drugs
Acetylcholine, carbachol and histamine were dissolved in KH solution; papaverine was dissolved in distilled water; R-, S-and racemic salbutamol were dissolved in distilled water;
indomethacin was dissolved in ethanol and the maximal amount of ethanol (0.02%) did not influence the response of isolated bronchi. Stock solutions (1 mM) of each of the tested substances were prepared in distilled water, diluted with KH solution and prepared fresh on each day of study. The substances were obtained from Sigma-Aldrich (St. Louis, USA), R-S-and racemic salbutamol were obtained from Stirling Products Ltd (Sydney, Australia) .
Results
Protocol 1: Relaxant effect of salbutamol enantiomers on submaximal contractions induced by carbachol or histamine
The baseline tension of bronchial tissues did not change throughout the experiments carried out with S-Salbutamol or the racemic mixture. In all bronchial rings the vehicle did not induce any relaxation of the bronchi. The contractile response to carbachol did not change in bronchi from RAO-affected horses, whereas the contractile potency of histamine was significantly enhanced in bronchi from RAO-affected horses (EC50 2.8µM±0.26), compared to tissue obtained from RAOunaffected horses. In RAO-affected bronchi, R-and S-enantiomers of salbutamol and the racemic mixture did not alter the concentration response curve to carbachol compared to control tissues (P>0.05). On the contrary, the contractile response to histamine was shifted leftwards by S-salbutamol (EC50 1.50µM±0.80, P<0.05) whereas it was shifted rightward by R-salbutamol (EC50 7.10 µM ±0.35, P<0.001). In bronchi from RAO-affected horses the racemate did not change the contraction induct by histamine (P>0.05) ( figure 2, table 3 ).
Discussion
Inhaled β 2 -agonists remain the first line treatment of acute symptoms of airway obstructive diseases in horses. Most commonly available β 2 -agonist preparations are racemic, i.e. they are composed of an equimolar mixture of R-and S-stereoisomers. Traditionally the Senantiomers were considered inert or at best weak β 2 -agonists [10] , but it is now recognized that the S-enantiomer can have adverse effect in the airways [2] . Thus, it has been documented in in vitro and in vivo experimental studies that S-salbutamol can be proinflammatory and have pro-constrictor effects in airways. These results are in agreement with clinical studies that have demonstrated that S-salbutamol can induce airway hyperresponsiveness in patients with asthma. It has been suggested that these paradoxical responses may be reduced by removing the dose of S-enantiomers [5, 11] . Besides, Rsalbutamol is now commonly available for the treatment of obstructive lung disease and further R-isomers preparations of β 2 -agonist are under development in man (3) Like human obstructive bronchial diseases, equine obstructive pulmonary disease, also known as heaves or recurrent airway obstruction (RAO), is a common equine chronic pulmonary disease, in which the prominent symptom is airway obstruction which is treated with β 2 agonists [8, 9] . Our present study shows that S-salbutamol has adverse proconstrictory effects in equine bronchi, particularly in bronchi from RAO-affected horses.
Previous studies carried out with isolated equine trachea have demonstrated that β 2agonists facilitate acetylcholine release from prejunctional cholinergic nerves by the stimulation of prejunctional β 2 -receptors localized on parasympathetic nerve endings [11, 12] . Moreover, the S-enantiomers of two β 2 -agonists (salbutamol and formoterol) elicited a significant increase in acetylcholine release in the presence of M 2 receptor blockade, and suggested a potential deleterious effect of (S)-β 2 agonists in the lungs of horses with RAO [13] . To our knowledge, this is the first paper to focus on the effects of the R-and S-enantiomers of salbutamol on isolated bronchi obtained from Either normal or RAO affected horses.
Our results are consistent with an effect of acetylcholine release, as demonstrated by Zhang and co-workers [12] [13] [14] . Furthermore, it has also been postulated that S-salbutamol has a possible agonistic effect on M 3 muscarinic receptors postjunctionally, via a mechanism that involves an increase of intracellular calcium in airway smooth muscle [13, 14] . According with this hypothesis, and considering that the affinity of S-isomer for βadrenoceptors is >100 fold lower than R-isomer, Mitra and coworkers suggested that Ssalbutamol could work as an agonist for muscarinic receptors cross-reacting with M 3 receptors, acting also as a calcium agonist [14] . Moreover, several studies have shown that an exaggerated cholinergic stimulation of airway smooth muscle causes a reduction in the ability of β 2 -agonists to relax airway smooth muscle [16, 17] . These results could suggest that both enantiomers of salbutamol could have deleterious effects in equine airways, particularly in RAO-affected horses. However, our results have demonstrated that Rsalbutamol functionally antagonized the carbachol concentration contraction curve in normal bronchi, but not in bronchi obtained from horses with RAO. Furthermore, Rsalbutamol postjunctionally inhibited the smooth muscle tone induced by both histamine and carbachol in a significant manner in both normal and RAO bronchi. In addition, on equine carbachol precontracted tracheal strips, we have provided evidence that Ssalbutamol had a modest, but significant, bronchoconstrictor effect [13, 18] . These data may support the deleterious role of S-salbutamol, particularly in RAO-affected horses, in which the β 2 -adrenergic receptor-G s -protein-adenylate cyclase system is significantly impaired in membranes of peripheral lung and bronchi, when compared with the segments from control animals [19] .
In contrast with the observations on carbachol precontracted equine bronchi, the results of our study demonstrated that R-salbutamol relaxed equine isolated airways contracted with histamine. Moreover, the cumulative concentration-contraction curve to histamine was significantly shifted rightward with a significant increase of its EC50 when both normal and RAO equine bronchi were incubated with R-salbutamol, compared to controls tissues.
Our findinge are in line with results obtained in bovine tracheal smooth muscle, in which the contraction induced by muscarinic agonists was relatively resistant to relaxation by β 2agonists, compared to the contraction induced by histamine [17] . In fact, this spasmogen induced a less marked calcium mobilization and influx when compared to that induced by methacholine [16] , which is less susceptible to elevations of c-AMP [20] .
As expected, we observed a less marked relaxant effect of S-salbutamol, that was significant only at the highest concentration and certainly less effective than papaverine. In addition, we found a significant leftward shift of the histamine cumulative concentration contraction curve, with an increase of histamine potency, when normal airways or bronchi from RAO-affected horses were incubated with S-salbutamol, compared to control tissues.
In line with these results, it has been documented that detrimental effects of the racemic mixture of β 2 -agonists are strictly related to the S-isomers [2, 6, 21, 22] . Although, Ssalbutamol induced a weak relaxation of equine isolated bronchi pre-contracted by histamine, it induced an increase in airway smooth muscle responsiveness to the cumulative dose response to this spasmogen in both normal and RAO bronchi. In agreement with these findings, racemic salbutamol induced an exaggerated conctractile response to histamine in airway tissues obtained from sensitized from guinea pigs [21] . It has been speculated that the pro-inflammatory and pro-constrictory activity of S-isomer, are mediated by the activation of transcriptional nuclear factor κB (NF-κB) as has been demonstrated in human isolated airways [23] ,. These findings were also confirmed in other animal models of bronchial hyperresponsiveness. Thus it has been reported that Ssalbutamol potentiates the pro-constrictory activity of histamine and IL-4 in sensitized guinea pigs [24] , by stimulating the production of IL-2 and IL-13 in T-cells [25] . Over all, these cytokines shift the coupling of the β 2 -adrenergic receptors to pro-constrictory G proteins such as G iα-1 protein [19] . Considering all these data, it is possible to hypothesize an analogous pro-inflammatory and pro-constrictory activity of S-salbutamol also in equine airways after only 90 min. of incubation,enhancing the potency of histamine, as has been demosntrated in human bronchi after passive sensitization [26] .
In conclusion, our studies demonstrated that S-salbutamol elicited a weak contraction of equine airway smooth muscle, but induced a significant hyperresponsiveness to histamine that could be detrimental particularly in RAO-affected horses [27] [28] [29] [30] . Our results suggest that it may be prudent to administrate the R-isomer alone in RAO horses to avoid detrimental effect of S-isomer. 
